摘要
目的评价已发表的中医药系统评价再评价(overview of systematic reviews,Overviews)报告的规范性。方法计算机检索中国知网、中国生物医学文献数据库及万方数据库,收集已发表的中医药相关的Overviews,检索时限为建库至2018年4月23日。应用Overviews优先报告条目(preferred reporting items for overview of systematic reviews,PRIO-harms)评价其报告的规范性。结果检索共获得题录968条,经筛选后共纳入21篇中医药相关的Overviews。纳入的Overviews包含的系统评价/Meta数目为5～69个,合计纳入362个系统评价。PRIO-harms报告规范评估结果显示条目5 "计划书与注册"(0/21)、条目10 "原始研究的补充检索"(0/21)、条目14 "Meta偏倚"(0/21)、条目18 "重复"(0/21)被完全忽视,完全报告占比最高的为条目7 "信息来源"(8/21),有38%。其余条目,尤其在涉及利害关系的条目中多为部分报告。结论中医药Overviews对不利指标及利害关系报告不明确,整体报告规范有待提高。建议参照PRIO-harms条目进行报告,以提高报告的完整性和透明度。
Objective To evaluate reporting condition of the published overview of systematic reviews of traditional Chinese medicine(TCM).Methods The published Chinese medicine related Overviews were collected and identified by searching China Knowledge Network(CNKI),China Biomedical Literature Database(CBM) and Wanfang Database from inception to 23 April 2018.The Preferred Reporting Items for Overview of systematic reviews(PRIO-harms) was used to assess the reporting condition.Results The searching identified 968 records and 21 were eligible for analysis finally.The included Overviews consisted of 5 to 69 systematic reviews,with a total of 362 systematic reviews.The PRIO-harms reporting quality assessment showed that the reporting of item 5 "protocol and registration"(0/21),item 10 "additional search for primary studies"(0/21),item 14 "Meta-bias(es) "(0/21)and item 18 "overlapping"(0/21) were totally neglected,while item 7 "information sources"(8/21) occupied the highest proportion 38% of all reports.The remaining items,especially for those involving harms,were mostly partreported.Conclusion The reporting specification of overviews of TCM was generally unclear,especially for those harm-related items,and the overall reporting specifications need to be improved.The PRIO-harms checklist should be applied as a guideline in reporting Overviews,so as to improve their integrity and transparency.
作者
王虎城
杨丰文
胡海殷
季昭臣
赵宏杰
张俊华
WANG Hucheng;YANG Fengwen;HU Haiyin;JI Zhaochen;ZHAO Hongjie;ZHANG Junhua(Evidence Based Medicine.Center,Tianjin University of Traditional Chinese Medicine,Tianjin 300193)
出处
《中医杂志》
CSCD
北大核心
2018年第23期2000-2005,共6页
Journal of Traditional Chinese Medicine
基金
国家自然科学基金(81473544)
天津市人才发展特殊支持计划(201504)
关键词
中医药系统评价
系统评价再评价
优先报告条目
报告规范
systematic reviews of traditional Chinese medicine
overview of systematic reviews
preferred reporting items for overview of systematic reviews including harms checklist
reporting quality
